Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204360 · ClinicalTrials.gov registry record
Pediatric Epilepsy Database
A clinical trial of Epilepsy, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 1
- Study location
NCT00204360 is a study of Epilepsy that has completed, run by University of Alabama at Birmingham. The trial reports 1 study location across 1 state.
The verdict
NCT00204360, a study of Epilepsy, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
The purpose of this database is to collect information for clinical purposes on all children being treated for seizure disorders.
Conditions Studied
Study Locations (1)
Alabama
- Children's Hospital of Alabama - Birmingham
Trial Details
| Field | Value |
|---|
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204360
The ClinicalTrials.gov registry entry for NCT00204360 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.
NCT00204360 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT00204360 about?
NCT00204360 is a clinical study titled "Pediatric Epilepsy Database". The purpose of this database is to collect information for clinical purposes on all children being treated for seizure disorders.
What is the current status of trial NCT00204360?
This trial is currently completed.
What conditions does trial NCT00204360 study?
This clinical trial studies the following conditions: Epilepsy.
Who is sponsoring clinical trial NCT00204360?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00204360 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.